Next Article in Journal
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Next Article in Special Issue
SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains—A Molecular and Clinical Approach
Previous Article in Journal
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
Previous Article in Special Issue
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
 
 
Review

Article Versions Notes

Vaccines 2021, 9(5), 436; https://doi.org/10.3390/vaccines9050436
Action Date Notes Link
article xml file uploaded 29 April 2021 09:21 CEST Original file -
article xml uploaded. 29 April 2021 09:21 CEST Update -
article pdf uploaded. 29 April 2021 09:21 CEST Version of Record https://www.mdpi.com/2076-393X/9/5/436/pdf-vor
article html file updated 29 April 2021 09:22 CEST Original file -
article xml file uploaded 29 April 2021 10:23 CEST Update -
article xml uploaded. 29 April 2021 10:23 CEST Update -
article pdf uploaded. 29 April 2021 10:23 CEST Updated version of record https://www.mdpi.com/2076-393X/9/5/436/pdf-vor
article html file updated 29 April 2021 10:24 CEST Update -
article xml file uploaded 30 April 2021 07:45 CEST Update -
article xml uploaded. 30 April 2021 07:45 CEST Update https://www.mdpi.com/2076-393X/9/5/436/xml
article pdf uploaded. 30 April 2021 07:45 CEST Updated version of record https://www.mdpi.com/2076-393X/9/5/436/pdf
article html file updated 30 April 2021 07:47 CEST Update -
article html file updated 26 July 2022 17:25 CEST Update https://www.mdpi.com/2076-393X/9/5/436/html
Back to TopTop